Switch to:
More From Other Websites
Invesco Adds to Holdings in Investment, Financial Services Companies Jul 01 2016
Roche's Multiple Sclerosis Drug Under Review by FDA, EMA Jun 29 2016
[video]Instead of Panicking on Brexit, Buy These Stocks Jun 28 2016
What Were Roche’s Breakthrough Therapy Designations in 2016? Jun 28 2016
What Were Roche’s Breakthrough Therapy Designations in 2015? Jun 28 2016
Roche anticipates quicker U.S. approval for new MS drug Jun 28 2016
FDA Grants Priority Review for Genentech’s OCREVUS™ (ocrelizumab) Biologics License Application Jun 28 2016
How Did Roche’s Diagnostics Division Perform? Jun 25 2016
How Was Roche’s Operational Performance in 2Q16? Jun 25 2016
Why Is Roche Trading at a Discount? Jun 23 2016
What Does Roche’s Valuation Indicate? Jun 23 2016
Roche receives FDA clearance for its Procalcitonin (PCT) assay to help clinicians effectively assess... Jun 23 2016
Epizyme Teams Up with Roche's Genentech for Tazemetostat Jun 23 2016
Roche CEO 'sleeps better' as risk to drugmaker's growth recedes Jun 22 2016
Roche CEO 'sleeps better' as risk to drugmaker's growth recedes Jun 22 2016
[$$] Brexit or Not, Adidas and Roche Offer Solid Returns Jun 17 2016
Merck Extends Cancer Immunotherapy Reach to First-Line Lung Cancer Jun 16 2016
Roche Presents Encouraging Data on Actemra and Tecentriq Jun 06 2016
Phase III Study Shows Genentech’s Actemra® (tocilizumab) Maintained Steroid-Free Remission in... Jun 06 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK